Innova Captab Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹977.80
-27.50-2.74% (1D)
As on 20 Nov 2026 at 15:58
As of 20 Nov 2026 at 15:58, Innova Captab Ltd is trading at ₹977.80. The 52-week range stands at ₹622.00–₹1,353.50, with a market cap of ₹5.60 thousand crore. At a P/E of 49.54 and a dividend yield of 0.20%, it is a mid-cap stock in the Pharmaceuticals sector.

INNOVACAP Price Chart

Market Cap
₹5.60K Cr
PE Ratio
49.54
ROCE
12.94%

Innova Captab Ltd Performance

Innova Captab Ltd Fundamentals

Know More
Market Cap₹5.60K Cr
ROE11.89%
P/E Ratio (TTM)49.54
EPS (TTM)₹19.76
P/B Ratio5.89
Dividend Yield0.20%
Industry P/E91.72
Book Value₹166.25
Debt to Equity0.35
Face Value₹10

Innova Captab Ltd Shareholding Pattern

Know More
Promoter50.9%
Foreign Institutions0.8%
Mutual Funds8.7%
Domestic Institutions10.5%
Public29.1%

Innova Captab Ltd Financial Statements

Know More
No data for this view.

Innova Captab Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Innova Captab

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private limited company at Mumbai. Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company got converted to a Public company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development & manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial large-scale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals. In 2006, the first manufacturing plant got established in Baddi, at Himachal Pradesh. In 2010, it commenced operations at the cephalosporin block of their plant in Baddi. In 2021, the Company acquired business of Innova Captab, a Partnership Firm, as a going concern through Slump Sale effective in March, 2021 and acquired Univentis Medicare Limited (UML) 100% equity shares effective on December 31, 2021 and consequently, The Univentis Foundation became a Subsidiary of Company on June 14, 2021. The Company commenced construction to establish an industrial plant in Jammu and Kashmir and to build an R&D center in Panchkula, Haryana in 2022. In December 2023, the Company came up with an IPO aggregating to Rs 570 Crores by issuing 12,723,214 Equity Shares, comprising 7,142,857 Equity Shares aggregating to Rs 320 Crore through Fresh Issue and 5,580,357 Equity Shares aggregating to Rs 250 Crore through Offer for Sale. The Company acquired Sharon Bio-Medicine Limited in June, 2023. In 2024-25, Company commissioned a new greenfield facility in Kathua, Jammu w.e.f. 14 January, 2025. Company's expanding international footprint, supported by fresh GMP certifications for the Baddi Cephalosporin unit and the Kathua, Jammu facility, has captured a growing share for global pharmaceutical trade in FY26.

Parent Organisation—
Founded2005
Managing DirectorVinay Kumar Lohariwala
NSE SymbolINNOVACAP

Innova Captab Ltd Resistance and Support levels

R31,074.97R21,053.23R11,039.80S1996.33S2982.90S3961.17977.80

Innova Captab Ltd Technicals

Current Price
₹977.80 ₹27.50 (-2.74%)
Bearish
10
Bullish
2
  • 20 Day7.7%
  • 50 Day8.5%
  • 100 Day5.8%
  • 200 Day0.8%

Innova Captab Ltd Latest News

View More
05 NOV 2026 | Thursday
Innova Captab to review quarterly and half-year financials at a board meeting
07 OCT 2026 | Wednesday
Innova Captab received a certificate from KFin Technologies regarding share holdings
29 SEPT 2026 | Tuesday
Innova Captab Ltd. receives credit rating upgrades from CARE Ratings and CareEdge Ratings
28 SEPT 2026 | Monday
Innova Captab closes trading window for insiders ahead of financial results release
03 SEPT 2026 | Thursday
Innova Captab to acquire land with an estimated Rs 50 crore investment
18 AUG 2026 | Tuesday
Innova Captab to revise financial statements following inadvertent errors identified
13 AUG 2026 | Thursday
Innova Captab closes securities trading window ahead of financial results release
06 AUG 2026 | Thursday
Innova Captab to review financial results at board meeting on August 11, 2026
05 JUN 2026 | Friday
Innova Captab AGM scheduled

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Annual ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Innova Captab Ltd is ₹977.80 as of 20 Nov 2026 at 15:58.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now